Inspire Medical Systems to Report Q1 2026 Earnings on May 4

The medical device company will host a conference call to discuss financial results and business updates.

Apr. 6, 2026 at 12:19pm

Got story updates? Submit your updates here. ›

Inspire Medical Systems, Inc., a medical technology company focused on innovative solutions for obstructive sleep apnea, will release its first quarter 2026 financial results after the market close on Monday, May 4. The company will host a conference call at 5:00 p.m. Eastern Time the same day to discuss the results and provide updates on its business.

Why it matters

As a leading provider of neurostimulation technology for treating sleep apnea, Inspire Medical Systems' quarterly earnings and business performance are closely watched by investors and industry analysts. The company's results and management commentary can provide insights into the state of the sleep apnea treatment market and the adoption of its Inspire therapy.

The details

Inspire will release its Q1 2026 financial results after the market close on May 4. The company will then host a conference call at 5:00 p.m. Eastern Time to discuss the results. A webcast of the call will be available on the company's Investor Relations website. Those planning to ask questions during the call can register through a separate link to receive dial-in details.

  • Inspire Medical Systems will release Q1 2026 financial results after market close on May 4, 2026.
  • The company will host a conference call to discuss the results at 5:00 p.m. Eastern Time on May 4, 2026.

The players

Inspire Medical Systems, Inc.

A medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Inspire Medical Systems' Q1 2026 earnings report and conference call for updates on the company's financial performance, product adoption, and market trends.

The takeaway

Inspire Medical Systems' quarterly earnings release and conference call provide important insights into the state of the sleep apnea treatment market and the performance of the company's innovative Inspire therapy. As a leading provider of neurostimulation solutions, Inspire's results are closely followed by industry stakeholders.